645 related articles for article (PubMed ID: 29663442)
1. Complexity of scar and ventricular arrhythmias in dilated cardiomyopathy of any etiology: Long-term data from the SCARFEAR (Cardiovascular Magnetic Resonance Predictors of Appropriate Implantable Cardioverter-Defibrillator Therapy Delivery) Registry.
Pedretti S; Vargiu S; Baroni M; Dellegrottaglie S; Lanzarin B; Roghi A; Milazzo A; Quattrocchi G; Lunati M; Pedrotti P
Clin Cardiol; 2018 Apr; 41(4):494-501. PubMed ID: 29663442
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy.
Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M
Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention.
Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods.
Jablonowski R; Chaudhry U; van der Pals J; Engblom H; Arheden H; Heiberg E; Wu KC; Borgquist R; Carlsson M
Circ Cardiovasc Imaging; 2017 Sep; 10(9):. PubMed ID: 28838961
[TBL] [Abstract][Full Text] [Related]
5. Prediction of arrhythmic events in ischemic and dilated cardiomyopathy patients referred for implantable cardiac defibrillator: evaluation of multiple scar quantification measures for late gadolinium enhancement magnetic resonance imaging.
Gao P; Yee R; Gula L; Krahn AD; Skanes A; Leong-Sit P; Klein GJ; Stirrat J; Fine N; Pallaveshi L; Wisenberg G; Thompson TR; Prato F; Drangova M; White JA
Circ Cardiovasc Imaging; 2012 Jul; 5(4):448-56. PubMed ID: 22572740
[TBL] [Abstract][Full Text] [Related]
6. Can QRS scoring predict left ventricular scar and clinical outcomes?
Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
[TBL] [Abstract][Full Text] [Related]
7. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
Scott PA; Rosengarten JA; Murday DC; Peebles CR; Harden SP; Curzen NP; Morgan JM
J Cardiovasc Electrophysiol; 2013 Apr; 24(4):430-6. PubMed ID: 23210601
[TBL] [Abstract][Full Text] [Related]
8. Mortality and Sudden Cardiac Death Risk Stratification Using the Noninvasive Combination of Wide QRS Duration and Late Gadolinium Enhancement in Idiopathic Dilated Cardiomyopathy.
Marume K; Noguchi T; Tateishi E; Morita Y; Kamakura T; Ishibashi K; Noda T; Miura H; Nishimura K; Nakai M; Yamada N; Tsujita K; Anzai T; Kusano K; Ogawa H; Yasuda S
Circ Arrhythm Electrophysiol; 2018 Apr; 11(4):e006233. PubMed ID: 29654132
[TBL] [Abstract][Full Text] [Related]
9. Scar heterogeneity on cardiovascular magnetic resonance as a predictor of appropriate implantable cardioverter defibrillator therapy.
Rayatzadeh H; Tan A; Chan RH; Patel SJ; Hauser TH; Ngo L; Shaw JL; Hong SN; Zimetbaum P; Buxton AE; Josephson ME; Manning WJ; Nezafat R
J Cardiovasc Magn Reson; 2013 Apr; 15(1):31. PubMed ID: 23574733
[TBL] [Abstract][Full Text] [Related]
10. Scar extent evaluated by late gadolinium enhancement CMR: a powerful predictor of long term appropriate ICD therapy in patients with coronary artery disease.
Alexandre J; Saloux E; Dugué AE; Lebon A; Lemaitre A; Roule V; Labombarda F; Provost N; Gomes S; Scanu P; Milliez P
J Cardiovasc Magn Reson; 2013 Jan; 15(1):12. PubMed ID: 23331500
[TBL] [Abstract][Full Text] [Related]
11. Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy.
Perazzolo Marra M; De Lazzari M; Zorzi A; Migliore F; Zilio F; Calore C; Vettor G; Tona F; Tarantini G; Cacciavillani L; Corbetti F; Giorgi B; Miotto D; Thiene G; Basso C; Iliceto S; Corrado D
Heart Rhythm; 2014 May; 11(5):856-63. PubMed ID: 24440822
[TBL] [Abstract][Full Text] [Related]
12. Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events.
Mikami Y; Cornhill A; Heydari B; Joncas SX; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Yee R; Merchant N; Lydell CP; Howarth AG; White JA
J Cardiovasc Magn Reson; 2016 Nov; 18(1):82. PubMed ID: 27839514
[TBL] [Abstract][Full Text] [Related]
13. Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy.
Piers SR; Everaerts K; van der Geest RJ; Hazebroek MR; Siebelink HM; Pison LA; Schalij MJ; Bekkers SC; Heymans S; Zeppenfeld K
Heart Rhythm; 2015 Oct; 12(10):2106-14. PubMed ID: 26004942
[TBL] [Abstract][Full Text] [Related]
14. Late gadolinium enhancement as a predictor of functional recovery, need for defibrillator implantation and prognosis in non-ischemic dilated cardiomyopathy.
Barison A; Aimo A; Ortalda A; Todiere G; Grigoratos C; Passino C; Camici PG; Aquaro GD; Emdin M
Int J Cardiol; 2018 Jan; 250():195-200. PubMed ID: 29107357
[TBL] [Abstract][Full Text] [Related]
15. Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization.
Alexandre J; Saloux E; Lebon A; Dugué AE; Lemaitre A; Roule V; Labombarda F; Champ-Rigot L; Gomes S; Pellissier A; Scanu P; Milliez P
Europace; 2014 Feb; 16(2):220-6. PubMed ID: 24186956
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes after primary prevention defibrillator implantation are better predicted when the left ventricular ejection fraction is assessed by cardiovascular magnetic resonance.
Champ-Rigot L; Gay P; Seita F; Benouda L; Morello R; Pellissier A; Alexandre J; Saloux E; Milliez P
J Cardiovasc Magn Reson; 2020 Jun; 22(1):48. PubMed ID: 32580786
[TBL] [Abstract][Full Text] [Related]
17. Prediction of life-threatening arrhythmic events in patients with chronic myocardial infarction by contrast-enhanced CMR.
Boyé P; Abdel-Aty H; Zacharzowsky U; Bohl S; Schwenke C; van der Geest RJ; Dietz R; Schirdewan A; Schulz-Menger J
JACC Cardiovasc Imaging; 2011 Aug; 4(8):871-9. PubMed ID: 21835379
[TBL] [Abstract][Full Text] [Related]
18. Association of cardiovascular magnetic resonance-derived circumferential strain parameters with the risk of ventricular arrhythmia and all-cause mortality in patients with prior myocardial infarction and primary prevention implantable cardioverter defibrillator.
Paiman EHM; Androulakis AFA; Shahzad R; Tao Q; Zeppenfeld K; Lamb HJ; van der Geest RJ
J Cardiovasc Magn Reson; 2019 May; 21(1):28. PubMed ID: 31096987
[TBL] [Abstract][Full Text] [Related]
19. The amount of late gadolinium enhancement outperforms current guideline-recommended criteria in the identification of patients with hypertrophic cardiomyopathy at risk of sudden cardiac death.
Freitas P; Ferreira AM; Arteaga-Fernández E; de Oliveira Antunes M; Mesquita J; Abecasis J; Marques H; Saraiva C; Matos DN; Rodrigues R; Cardim N; Mady C; Rochitte CE
J Cardiovasc Magn Reson; 2019 Aug; 21(1):50. PubMed ID: 31412875
[TBL] [Abstract][Full Text] [Related]
20. Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.
Disertori M; Rigoni M; Pace N; Casolo G; Masè M; Gonzini L; Lucci D; Nollo G; Ravelli F
JACC Cardiovasc Imaging; 2016 Sep; 9(9):1046-1055. PubMed ID: 27450871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
